Frequency of Hypoglycemia and Its Significance in Chronic Kidney Disease
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: This study set out to determine the incidence of hypoglycemia in patients with chronic kidney disease (CKD), with and without diabetes, and the association of hypoglycemia with mortality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a retrospective cohort analysis of 243,222 patients who had 2,040,206 glucose measurements and were cared for at the Veterans Health Administration. CKD was defined as an estimated GFR of <60 ml/min per 1.73 m(2). Hypoglycemia was set at <70 mg/dl. Mortality was measured 1 day after glucose measurement. RESULTS: The incidence of hypoglycemia was higher in patients with CKD versus without CKD. Among patients with diabetes, the rate was 10.72 versus 5.33 per 100 patient-months and among patients without diabetes was 3.46 versus 2.23 per 100 patient-months, for CKD versus no CKD, respectively. The odds of 1-d mortality were increased at all levels of hypoglycemia but attenuated in CKD versus no CKD. Adjusted odds ratios for 1-d mortality that were associated with glucose values of <50, 50 to 59, and 60 to 69 mg/dl, respectively, versus glucose of >or=70 mg/dl were 6.09, 4.10, and 1.85 for inpatient records from patients with CKD; 9.95, 3.79, and 2.54 for inpatients records from patients without CKD; 6.84, 3.28, and 3.98 for outpatient records from patients with CKD; and 13.28, 7.36, and 4.34 for outpatient records from patients without CKD. CONCLUSIONS: CKD is a risk for hypoglycemia, with or without diabetes. The excessive mortality associated with hypoglycemia makes this complication a significant threat to patient safety in CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“CKD is a risk factor for non-diabetic hypoglycemia, as reflected in significantly higher hypoglycemia rates in patients with CKD compared to patients without CKD (3.46 vs. 2.23/100 patient-months, p < 0.0001) [29].”
From Non-Diabetic Hypoglycemia: Evaluation and Management in Adults (2025) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Both the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) and the Veterans Affairs Diabetes Trial (VADT) found that severe hypoglycemia was more common in an intensive glucose-lowering group than a control group, but the two treatment groups had similar m…”
BackgroundMethodInfluential(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Gerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes
Leese, G. P., Wang, J., Broomhall, J., Kelly, P., Marsden, A., Morrison, W., Frier, B. M., Morris, A. D., & For the DARTS/MEMO Collaboration (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1176 · Cited by 559 · cited 1×
“The selection of these cut points was derived from definitions of hypoglycemia used in previous studies (5, 17 ,18), but because none of them was used exclusively, we elected to incorporate all of them as measures of hypoglycemic severity.”
MethodMechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia
Robinson, R. T. C. E., Harris, N. D., Ireland, R. H., Lee, S., Newman, C., & Heller, S. R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1469 · Cited by 264 · cited 2×
“In addition, acute hypoglycemia can result in a surge in adrenergic activity, which can result in coronary ischemia, serious cardiac arrhythmias, and sudden death (7).”
BackgroundValidation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits
Ginde, A. A., Blanc, P. G., Lieberman, R. M., & Camargo, C. A. (2008) · BMC Endocrine Disorders · doi:10.1186/1472-6823-8-4 · Cited by 234
Snyder, R. W., & Berns, J. S. (2004) · Seminars in Dialysis · doi:10.1111/j.0894-0959.2004.17346.x · Cited by 215
Research works printed but not linked: 1
- [6]Berlin KS, Sass DA, Davies WH, Reupert S, Hains AA: Brief report: Parent perceptions of hypoglycemic symptoms in youth with diabetes. J Pediatr Psychol 30: 207–212, 2005 [DOI] [PubMed] [Google Scholar]
Cited by
Items 101–200 of 428
Wada, N., Mori, K., Nakagawa, C., Sawa, J., Kumeda, Y., Shoji, T., Emoto, M., & Inaba, M. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.07.002 · Cited by 34
“In fact, the presence of renal dysfunction in patients with DMwas a significant risk factor for severe hypoglycemia (Moen et al., 2009).”
BackgroundHenry, R. R., Frías, J. P., Walsh, B., Skare, S., Hemming, J., Burns, C. M., Bicsak, T. A., Baron, A., & Fineman, M. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203946 · Cited by 35
Rhee, C. M., Kovesdy, C. P., You, A. S., Sim, J. J., Soohoo, M., Streja, E., Molnar, M. Z., Amin, A., Abbott, K. C., Nguyen, D. V., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.04.022 · Cited by 35
“73 m2 21 [16-31] 23 [17-33] 21 [16-30] <0.”
Betônico, C. C., Titan, S. M. O., Lira, A., Pelaes, T. S., Correa-Giannella, M. L. C., Nery, M., & Queiroz, M. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.07.011 · Cited by 32
Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registry
Kong, A. P. S., Yang, X., Luk, A. O. Y., Cheung, K. K., Ronald, C. W., So, W. Y., Ho, C. S., Chan, M. H. M., Ozaki, R., Chow, C. C., et al. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-48 · Cited by 35
“Besides malnutrition and reduced gluconeogenesis (approximately one fifth of plasma glucose originated from renal gluconeogenesis), diabetic patients with CKD often have altered drug metabolism and autonomic neuropathy with hypoglycaemic unawareness, which put them at high risk of hypoglycaemia [27].”
BackgroundInsulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
Lau, I. T., Lee, K. F., So, W. Y., Tan, K. C. B., & Yeung, M. W. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s131358 · Cited by 33
Batista, R. A. B., Japúr, C. C., Prestes, I. V., Silva, J. F., Cavanha, M., & Pena, G. D. G. (2021) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12846 · Cited by 35
Eckert‐Norton, M., & Kirk, S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-v98i10-39a · Cited by 32
Lo, C., Toyama, T., Oshima, M., Jun, M., Chin, K. L., Hawley, C. M., & Zoungas, S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009966.pub3 · Cited by 30
Chiang, C., Ueng, K.-C., Chao, T., Lin, T., Wu, Y.-J., Wang, K.-L., Sung, S., Yeh, H., Li, Y., Liu, P., et al. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000359 · Cited by 31
“124 In other words, glucose management in diabetic patients with CKD should be a balance between glycemic control to reduce the progression of kidney disease and the avoidance of hypoglycemia.”
Hypoglycemia and Comorbidities in Type 2 Diabetes
Kong, A. P. S., & Chan, J. C. N. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0646-x · Cited by 31
Habte‐Asres, H. H., Murrells, T., Nitsch, D., Wheeler, D. C., & Forbes, A. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110117 · Cited by 34
“…with declining kidney function contributing to variability by impacting on insulin excretion rates and erythrocyte survival [26]; and with glucose fluctuations driving the inflammatory process that causes kidney disease by damaging microvascular structures and impeding endothelial function [27,28].”
BackgroundDejager, S., Penfornis, A., Blickle, J., Fiquet, B., & Quéré, S. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s60312 · Cited by 31
Schweizer, A., & Dejager, S. (2013) · Diabetes Therapy · doi:10.1007/s13300-013-0027-x · Cited by 29
“33 in those without chronic kidney disease [12].”
BackgroundEvaluation of Serum Glucose and Kidney Disease Progression Among Patients With Diabetes
Jung, H. H. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.27387 · Cited by 30
Patient-Reported and Actionable Safety Events in CKD
Ginsberg, J. S., Zhan, M., Diamantidis, C. J., Woods, C. M., Chen, J., & Fink, J. C. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090921 · Cited by 29
Self-citationSugiyama, S., Jinnouchi, H., Yoshida, A., Hieshima, K., Kurinami, N., Jinnouchi, K., Tanaka, M., Suzuki, T., MIYAMOTO, F., Kajiwara, K., et al. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3761 · Cited by 31
“In patients with severely impaired kidney function, treatment options for hyperglycemia are limited because of drug metabolic pathways, side effects, and the risk of hypoglycemia [8, 9].”
BackgroundHypoglycemia at the time of Covid-19 pandemic
Shah, K., TIWASKAR, M. H., CHAWLA, P. M., Kale, M. C., Deshmane, R., & Sowani, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.07.003 · Cited by 31
“The confluence of these factors may contribute to a greater risk for hypoglycemia among patients with CKD andmay be an unintended consequence of therapy to treat hyperglycemia [26].”
BackgroundHypoglycemia and Mortality Risk in Incident Hemodialysis Patients
Kang, D., Streja, E., You, A. S., Lee, Y.-K., Narasaki, Y., Rivera, S. T., Novoa-Vargas, A., Kovesdy, C. P., Kalantar‐Zadeh, K., & Rhee, C. M. (2023) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2023.09.001 · Cited by 29
Weir, M. A., Gomes, T., Mamdani, M., Juurlink, D. N., Hackam, D. G., Mahon, J. L., Jain, A. K., & Garg, A. X. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq649 · Cited by 34
“The risk of hypoglycaemia is a particular concern among patients with impaired renal function [12].”
BackgroundInfluentialSilva, T. P., Rolim, L. C., Filho, C. S., Zimmermann, L. M., Malerbi, F. K., & Dib, S. A. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2830 · Cited by 29
Pan, C.-C., Kung, P., Chiu, L.-T., Liao, Y. P., & Tsai, W. (2017) · PubMed · Cited by 28
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease
Rhee, C. M., Kalantar‐Zadeh, K., & Tuttle, K. R. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000756 · Cited by 27
Kushner, P. R., Cavender, M. A., & Mende, C. W. (2022) · Clinical Diabetes · doi:10.2337/cd21-0119 · Cited by 29
“CKD is an independent risk factor for hypoglycemia (57), and concomitant use of SGLT2 inhibitors with sulfonylureas or insulin may increase the risk of hypoglycemia (58).”
BackgroundGlucose Homeostasis, Hypoglycemia, and the Burnt-Out Diabetes Phenomenon in Kidney Disease
Rhee, C. M., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2021) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2021.03.004 · Cited by 27
Maxwell, A. P., Linden, K., O’Donnell, S., Hamilton, P., & McVeigh, G. (2013) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2013.312 · Cited by 27
Characteristics of Patients With Sulphonurea-Induced Hypoglycemia
Schejter, Y. D., Turvall, E., & Ackerman, Z. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.07.014 · Cited by 28
Roumie, C. L., Min, J. Y., Greevy, R. A., Grijalva, C. G., Hung, A. M., Liu, X., Elasy, T. A., & Griffin, M. R. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.150904 · Cited by 28
Rubin, D. J., & Golden, S. H. (2013) · Hospital Practice · doi:10.3810/hp.2013.02.1016 · Cited by 28
Glucose-Lowering Agents and the Risk of Hypoglycemia: a Real-world Study
Lyu, B., Hwang, Y. J., Selvin, E., Jameson, B. C., Chang, A. R., Grams, M. E., & Shin, J. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07726-8 · Cited by 27
Efficacy and safety of vildagliptin in clinical practice-results of the PROVIL-study
Blüher, M., Kurz, I., Dannenmaier, S., & Dworak, M. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i9.161 · Cited by 29
Integrating oral semaglutide into clinical practice in primary care: for whom, when, and how?
Brunton, S., Mosenzon, O., & Wright, E. E. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1798162 · Cited by 31
Patient Safety Issues in CKD: Core Curriculum 2015
Wagner, L.-A., Tata, A. L., & Fink, J. C. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.02.343 · Cited by 25
Self-citationKaewput, W., Thongprayoon, C., Varothai, N., Sirirungreung, A., Rangsin, R., Bathini, T. J., Mao, M. A., & Cheungpasitporn, W. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i3.212 · Cited by 28
Executive summary of clinical practice guide on fracture risk in lifestyle diseases
Kanazawa, I., Inaba, M., Inoue, D., Uenishi, K., Saito, M., Shiraki, M., Suzuki, A., Takeuchi, Y., Hagino, H., Fujiwara, S., et al. (2020) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-020-01149-3 · Cited by 25
Urata, H., Mori, K., Emoto, M., Yamazaki, Y., Motoyama, K., Morioka, T., Fukumoto, S., Koyama, H., Shoji, T., Ishimura, E., et al. (2014) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2014.07.011 · Cited by 25
The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia
Crnobrnja, L., Metlapalli, M., Jiang, C., Govinna, M., & Lim, A. K. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-79180-7 · Cited by 26
Wu, P., Wu, V., Lin, C., Pan, C., Chen, C.-Y., Huang, T., Wu, C., Chen, L., & Wu, C. (2017) · Oncotarget · doi:10.18632/oncotarget.17475 · Cited by 26
“Altered pharmacokinetics of anti-diabetic agents in CKD patients, decreased renal clearance, peripheral degradation of insulin, and impaired renal gluconeogenesis are all predisposed to the occurrence of hypoglycemia [7].”
BackgroundŠimić, S., Svaguša, T., Prkačin, I., & Bulum, T. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00460-9 · Cited by 27
Bomholt, T., Idorn, T., Knop, F. K., Jørgensen, M. B., Ranjan, A. G., Resuli, M., Hansen, P. M., Borg, R., Persson, F., Feldt‐Rasmussen, B., et al. (2020) · The Nephron journals/Nephron journals · doi:10.1159/000510613 · Cited by 26
Effects of Alogliptin in Chronic Kidney Disease Patients with Type 2 Diabetes
Sakai, Y., Suzuki, A., Mugishima, K., Sumi, Y., Otsuka, Y., Otsuka, T., Ohno, D., Murasawa, T., & Tsuruoka, S. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.1292 · Cited by 27
“Indeed, patients with diabetes whose renal function is deteriorated have more hypoglycemic episodes (8-10).”
BackgroundKim, H. M., Seong, J.-M., & Kim, J. (2016) · Medicine · doi:10.1097/md.0000000000005016 · Cited by 28
Escalada, J., Halimi, S., Senior, P. A., Bonnemaire, M., Cali, A. M. G., Melas‐Melt, L., Karalliedde, J. J., & Ritzel, R. A. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13470 · Cited by 23
“Diabetes and chronic kidney disease (CKD) are common chronic comor- bid conditions, with diabetic kidney disease accounting for approximately half of all end-stage renal disease cases in developed countries.1 The US National Health and Nutrition Examination Survey (NHANES) reported that ~40% of survey participants wit…”
ResultInfluentialYu, H.-C., Tsai, W., & Kung, P. (2013) · Health Policy and Planning · doi:10.1093/heapol/czt056 · Cited by 23
“A recent study showed that diabetic patients with poor health status have an elevated risk of requiring emergency care for severe hypoglycaemia (Moen et al. 2009).”
BackgroundPrevalence and predictors of hypoglycemia in older outpatients with type 2 diabetes mellitus
Al‐Azayzih, A., Kanaan, R. J., Altawalbeh, S. M., Alzoubi, K. H., Kharaba, Z. J., & Jarab, A. S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309618 · Cited by 24
Incretin Therapies in the Management of Patients with Type 2 Diabetes Mellitus and Renal Impairment
Dejager, S., & Schweizer, A. (2012) · Hospital Practice · doi:10.3810/hp.2012.04.965 · Cited by 22
“In particular, overexposure to insulin secretagogues (SUs and glinides) is often associated with an increased risk of hypoglycemia,(22) which can contribute to coronary ischemia, serious cardiac arrhythmias, and sudden death.(23,24) In addition, because of decreased renal neoglycogenesis, hypoglycemia is already more…”
BackgroundChiang, C., Lin, S.-Y., Lin, T., Wang, T., Yeh, H., Chen, J., Tsai, C., Hung, Y.-J., Li, Y., Liu, P., et al. (2018) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2018.01.001 · Cited by 22
“73 m(2).(93) In other words, glucose management in diabetic patients with CKD should be a balance between glycemic control to reduce the progression of kidney disease and the avoidance of hypoglycemia.”
BackgroundDefining, Treating, and Understanding Chronic Kidney Disease—A Complex Disorder
Campbell, D., & Weir, M. R. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12560 · Cited by 24
“Metabolic acidosis, when left untreated, likely contributes to progression from early to later stages of CKD, according to multiple small single center trials.(33) A study of 134 patients by Brito-Ashurst and colleagues(34) in 2009 found a slower decline in creatinine clearance, decreased progression to ESRD, and impr…”
BackgroundLiaw, J., Harhay, M., Setoguchi, S., Gerhard, T., & Dave, C. V. (2022) · Diabetes Care · doi:10.2337/dc22-0224 · Cited by 21
Medication Issues in Older Individuals With CKD
Rifkin, D. E., & Winkelmayer, W. C. (2010) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2010.03.005 · Cited by 21
Hypoglycemia and diabetes: increased need for awareness
Shaefer, C. F., Hinnen, D., & Sadler, C. E. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1163255 · Cited by 22
Adverse safety events in patients with Chronic Kidney Disease (CKD)
Offurum, A. I., Wagner, L.-A., & Gooden, T. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1236909 · Cited by 23
“While glycemic control is important in diabetics with CKD, hypoglycemia can be a common safety threat [6].”
BackgroundCheng, A. Y. Y., Wong, J., Freemantle, N., Acharya, S. H., & Ekinci, E. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00925-8 · Cited by 20
Fukami, K., Shibata, R., Nakayama, H., Yamada, K., Okuda, S., & Koga, M. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.06.003 · Cited by 21
“According to the ACCORD study (Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Group, 2008), hypoglycemia is a risk of cardiovascular disease as well, and the risk of hypoglycemia is much higher in patients with renal dysfunction than those without it (Moen et al., 2009).”
BackgroundMethodIncreasing awareness of hypoglycaemia in patients with Type 2 diabetes treated with oral agents
Barnett, A. H., Brice, R., Hanif, W., James, J., & Langerman, H. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.834250 · Cited by 20
Diabetes mellitus in dialysis and renal transplantation
Ben-David, E., Hull, R., & Banerjee, D. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211048663 · Cited by 23
Insulin use in chronic kidney disease and the risk of hypoglycemic events
Grube, D., Wei, G., Boucher, R. E., Abraham, N., Zhou, N., Gonce, V., Carle, J., Simmons, D. L., & Beddhu, S. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02687-w · Cited by 21
“Some of the previous studies noted such an association [45, 46] but not all [9].”
ResultORGANISING CARE FOR PEOPLE WITH DIABETES AND RENAL DISEASE
Dean, J. D. (2012) · Journal of Renal Care · doi:10.1111/j.1755-6686.2012.00272.x · Cited by 20
Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine
Tuot, D. S., Lin, F., Shlipak, M. G., Grubbs, V., Hsu, C., Yee, J., Shahinian, V. B., Saran, R., Saydah, S., Williams, D. E., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0542 · Cited by 20
“rather than a sulfonylurea or thiazolidinedione (23,24).”
Shih, C.-J., Wu, Y.-L., Lo, Y., Kuo, S., Tarng, D., Lin, C., Ou, S., & Chen, Y. (2015) · Medicine · doi:10.1097/md.0000000000000771 · Cited by 22
“However, hypoglycemia was also found to be a common complication among patients with DM and preserved kidney function in a cohort of US veterans.(21) A community-based study found that the risk of severe hypoglycemia was similar across patients with all levels of glycemic control (ie, those with glycosylated hemoglobi…”
BackgroundHow Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting
Kulasa, K. M., & Juang, P. S. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0902-3 · Cited by 21
Consenso sobre tratamiento con insulina en la diabetes tipo 2
Borrás, J. A. G., Escalada, J., Mata‐Cases, M., Peralta, F. G., Menéndez, S. A., García, D. F., Millán, C. O., Guisasola, F. Á., García, J. C. F., Loiola, P. E., et al. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.01.002 · Cited by 25
Hsiao, C.-C., Tu, H., Lin, C., Chen, K., Yeh, Y., & See, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040420 · Cited by 20
“In another large population-based study involving 243,222 veterans, the incidence of hypoglycemia, which was defined by blood glucose level <70 mg/dL, was higher in patients with CKD versus without CKD [6].”
BackgroundInfluentialGuzmán, G. E., Martínez, V., Yara, J., Mina, M. A., Solarte, J. S., Victoria‐Castro, A. M., & Fériz, K. (2020) · Journal of Diabetes Research · doi:10.1155/2020/1581726 · Cited by 19
“73m(2) constitutes a risk factor for developing hypoglycemia; there is a 3-, 7-, and 8-fold risk for hypoglycemia with a GFR of 70, 60, and 50mg/dL, respectively [30].”
BackgroundPhysiological Mechanisms of Hypertension and Cardiovascular Disease in End-Stage Kidney Disease
Clemmer, J. S., Shafi, T., & Obi, Y. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01203-7 · Cited by 20
Heller, S. R., DeVries, J. H., Wysham, C., Hansen, C. T., Hansen, M. V., & Frier, B. M. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13708 · Cited by 18
McGill, J. B., Barnett, A. H., Lewin, A. J., Patel, S. D., Neubacher, D., von Eynatten, M., & Woerle, H. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113507068 · Cited by 18
Williams, M. E., Garg, R., Wang, W., Lacson, R. C., Maddux, F. W., & Lacson, E. (2013) · Hemodialysis International · doi:10.1111/hdi.12110 · Cited by 18
Options for empagliflozin in combination therapy in type 2 diabetes mellitus
Thompson, G., & Hershon, K. S. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s100288 · Cited by 21
“Patients with advanced renal impairment are a difficult-totreat population due to the presence of associated comorbidities, reduced drug elimination, and an increased risk of hypoglycemia.(49) Empagliflozin is contraindicated in patients with severe or end-stage renal disease (and would not be expected to have efficac…”
Elnaem, M. H., Mansour, N. O., Nahas, A. R. F., Baraka, M. A., Elkalmi, R. M., & Cheema, E. U. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s285191 · Cited by 20
Hannah, K. L., Nemlekar, P. M., Johnson, M. L., Cherñavvsky, D. R., & Norman, G. J. (2024) · Kidney360 · doi:10.34067/kid.0000000000000396 · Cited by 17
“20 In addition, the KDIGO ’ s guideline on the treatment of patients with diabetes and CKD suggests the use of CGM to help patients achieve glycemic targets.”
BackgroundSinghsakul, A., Supasyndh, O., & Satirapoj, B. (2019) · Journal of Diabetes Research · doi:10.1155/2019/6923543 · Cited by 17
“Deficient gluconeogenesis, along with malnutrition, deficient catecholamine release, and impaired renal insulin degradation and clearance, can contribute to decreasing insulin requirements and frequent hypoglycemia among patients with ESRD [9, 10].”
BackgroundAccess to emergency room for hypoglycaemia in people with diabetes
Salutini, E., Bianchi, C., Santini, M., Dardano, A., Daniele, G., Penno, G., Miccoli, R., & Prato, S. D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2667 · Cited by 18
“This is well in keeping with the notion that risk for hypoglycaemia increases in the presence of either diabetes or chronic kidney disease, with the risk being most pronounced in the presence of both conditions [32].”
BackgroundWhat can we learn from the recent blood glucose lowering megatrials?
Chan, J. C. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00063.x · Cited by 17
Frankel, A., Kazempour‐Ardebili, S., Bedi, R., Chowdhury, T. A., De, P., El‐Sherbini, N., Game, F. L., Gray, S., Hardy, D., James, J., et al. (2016) · British Journal of Diabetes · doi:10.15277/bjd.2016.073 · Cited by 21
Yoshii, H., Mita, T., Katakami, N., Okada, Y., Osonoi, T., Aso, K., Kurozumi, A., Wakasugi, S., Sato, F., Ishii, R., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac459 · Cited by 17
Yunir, E., Nugraha, A. R. A., Rosana, M., Kurniawan, J., Iswati, E., Sarumpaet, A., Tarigan, T. J. E., & Tahapary, D. L. (2023) · Scientific Reports · doi:10.1038/s41598-023-43459-2 · Cited by 18
“The current study also found that hypoglycemia is higher in patients with CKD than those without CKD due to the decreasing insulin degradation in peripheral tissue 28 .”
BackgroundSandler, V., Misiasz, M. R., Jones, J. D., & Baldwin, D. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814540870 · Cited by 16
“Furthermore, each hypoglycemic event was associated with increased 1-day mortality, and the degree of risk was directly related to the severity of hypoglycemia.(17) Treatment of diabetic patients with chronic renal failure and ESRD inevitably involves balancing glycemic control with prevention of hypoglycemia.”
BackgroundThe impact of severe hypoglycemia on renal impairment in type 2 diabetes
Lee, Y.-L., Chen, B., Lin, K., Su, R.-W., Lee, M., Hsiao, P., & Shin, S. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.02.028 · Cited by 17
“Underreporting of asymptomatic and symptomatic hypoglycemic events is a commonly accepted problem with hypoglycemia [30,31].”
BackgroundLamine, F., Lalubin, F., Pitteloud, N., Burnier, M., & Zanchi, A. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14282 · Cited by 20
Achieving glycaemic targets with basal insulin in T2DM by individualizing treatment
Fonseca, V. A., & Haggar, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.17 · Cited by 19
Grenier, J., Leiter, L. A., Langer, A., Goldin, L., Teoh, H., Connelly, K. A., CHENG, A. Y. Y., Tan, M., FITCHETT, D. H., McGuire, D. K., et al. (2016) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcw013 · Cited by 17
Dejager, S., Penfornis, A., Fiquet, B., & Blicklé, J. F. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s83897 · Cited by 22
“The patients were not only old, and as such more susceptible to severe events because of marked decreased hypoglycemia awareness as outlined above,(31) but also they had renal disease which is an additional significant risk factor of hypoglycemia, in part due to impaired renal neoglycogenesis(38) and to differential c…”
BackgroundRosa, M. D., D’Alia, S., Guarasci, F., Soraci, L., Pierpaoli, E., Lenci, F., Ricci, M., Onder, G., Volpato, S., Ruggiero, C., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072202 · Cited by 15
“Cognitive impairment may worsen adherence to antidiabetic medications [52] and reduce the awareness of hypoglycemic warning symptoms, thus increasing the risk of silent hypoglycemia further contributing to cognitive deterioration [53].”
BackgroundMbanya, J. C., Aschner, P. J., Gagliardino, J. J., ILKOVA, H. M., Lavalle-Gonzalez, F. J., Ramachandran, A., Chantelot, J.-M., & Chan, J. C. N. (2021) · Diabetologia · doi:10.1007/s00125-021-05406-6 · Cited by 16
“Development of CKD increases the risk of hypoglycaemia and treatment complexity in patients with diabetes [4, 5].”
BackgroundKaneko, K., Satake, C., Izumi, T., Tanaka, M., Yamamoto, J., Asai, Y., Sawada, S., Imai, J., Yamada, T., & Katagiri, H. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0326-3 · Cited by 15
Cases, A. (2023) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2023.09.003 · Cited by 16
“…type 2 (iSGLT2) inhibitors is reduced as glomerular filtration rate (GFR) decreases, especially if GFR 45 ml/min/1.73 Furthermore, in patients 16 17 18 why guidelines insist on comprehensive management of the patient with diabetes (glycemic control and control of cardiovascular risk factors,…”
InfluentialA single-arm pilot study of metformin in patients with autosomal dominant polycystic kidney disease
Sorohan, B. M., Ismail, G., Andronesi, A. G., Micu, G., Obrișcă, B., Jurubiță, R. A., Sinescu, I. C., & Baston, C. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1463-2 · Cited by 15
“Hypoglycemia is a rare event in patients treated with Metformin, but the risk of hypoglycemia increases in those with CKD [19, 20].”
BackgroundBowman, C., Lunyera, J., Alkon, A., Boulware, L. E., Russell, J. S. C., Riley, J. A., Fink, J. C., & Diamantidis, C. J. (2020) · JMIR Formative Research · doi:10.2196/16137 · Cited by 16
“For example, individuals with CKD and concomitant diabetes who are on antidiabetic medications are at heightened risk of developing hypoglycemia due to the delayed renal clearance of these therapies [2].”
Self-citationAga, F., Dunbar, S. B., Kebede, T., Higgins, M. K., & GARY, R. A. (2020) · Nursing Open · doi:10.1002/nop2.517 · Cited by 15
“…with diabetes-related end-organ failure predicted poor control of bothHbA1c and FBG. Previous studies have shown that chronic kidney disease (CKD) is an independent predictor of hypoglycaemia, which is in turn associated with increased risk of mortality in T2D (Chu et al., 2017; Moen et al., 2009).”
BackgroundUemura, F., Okada, Y., Mita, T., Torimoto, K., Wakasugi, S., Katakami, N., Yoshii, H., Matsushita, K., Nishida, K., Inokuchi, N., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0465 · Cited by 15
Management of diabetes in dialysis patients
Williams, M. E. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0076-8 · Cited by 17
“In a recent US study of military veterans observed over 1 year during which each had at least one acute hospital admission, CKD and diabetes were independent risk factors for hypoglycemia, and the risk of mild to severe hypoglycemia was greater in the presence of both diseases [ 44 ].”
BackgroundSodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing
Li, J., Fagbote, C. O., Zhuo, M., Hawley, C. E., & Paik, J. M. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz100 · Cited by 15
“Diabetes and CKD together compound the risk for incident hypoglycemia, which is associated with excess mortality [69].”
BackgroundInsulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
Lo, C., Toyama, T., Hirakawa, Y., Jun, M., Cass, A., Hawley, C. M., Pilmore, H., Badve, S. V., Perkovic, V., & Zoungas, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011798 · Cited by 14
Non-Diabetic Hypoglycemia: Evaluation and Management in Adults
Looi, E., & Lawler, H. M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134393 · Cited by 13
“CKD is a risk factor for non-diabetic hypoglycemia, as reflected in significantly higher hypoglycemia rates in patients with CKD compared to patients without CKD (3.46 vs. 2.23/100 patient-months, p < 0.0001) [29].”
InfluentialKawahara, T., Tsuji, M., Tominaga, N., Toyama, N., & Toda, M. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac119 · Cited by 13
“Some [45, 46] but not all [47] previous studies have noted such an association.”
ResultUtsunomiya, K., Koshida, R., Kakiuchi, S., Senda, M., Fujii, S., Kurihara, Y., Gunji, R., & Kaku, K. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13333 · Cited by 14
Kaewput, W., Thongprayoon, C., Rangsin, R., Bathini, T. J., Torres‐Ortiz, A., Mao, M. A., & Cheungpasitporn, W. (2020) · Endocrine Research · doi:10.1080/07435800.2020.1792921 · Cited by 15
Frequency of Hypoglycemia Assessed by Continuous Glucose Monitoring in Advanced CKD
Ushiogi, Y., Kanehara, H., & Kato, T. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000102 · Cited by 13
The Primary Care Physician/Nephrologist Partnership in Treating Chronic Kidney Disease
Baldwin, M. D. (2014) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2014.08.004 · Cited by 13
“There is a significant risk of death within 1 day of a hypoglycemic episode in all patients, but especially in those with CKD, according to a 2009 study (Box 7).(33)”
Background
Metadata
- Authors
- Moen, M. F., Zhan, M., Hsu, V. D., Walker, L. D., Einhorn, L. M., Seliger, S. L., & Fink, J. C.
- Affiliations
- University of Maryland, Baltimore (US)
- Corresponding author
- Fink, Jeffrey C.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2009-06
- Volume
- 4
- Issue
- 6
- Pages
- 1121-1127
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC2689888
- OpenAlex
- W2146702281
- Semantic Scholar
- 6dd714ce42c6670e1867d104de400f22b50a7e1c
- Cited by
- 423
- References
- 18
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 21 · 2023: 22 · 2022: 28 · 2021: 32 · 2020: 47 · 2019: 31 · 2018: 37 · 2017: 26 · 2016: 27 · 2015: 36 · 2014: 26 · 2013: 23 · 2012: 19
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK075675)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- hypoglycemia, chronic kidney disease, diabetes mellitus, mortality, incidence, estimated glomerular filtration rate, veterans, patient safety, glucose monitoring
- MeSH terms
- Aged, Blood Glucose, Diabetic Nephropathies, Female, Glomerular Filtration Rate, Humans, Hypoglycemia, Male, Middle Aged, Retrospective Studies, Risk Factors, Comorbidity, Incidence, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.